首页> 外文OA文献 >PCV98 The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

【2h】

PCV98 The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

机译：PCV98达比加群酯与华法林相比在英国急性静脉血栓栓塞的治疗和二级预防中的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jugrin A.V.; Ustyugova A.V.; Urbich M.; Lamotte M.; Sunderland T.J.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. COST-EFFECTIVENESS OF EDOXABAN COMPARED TO WARFARIN FOR THE TREATMENT AND SECONDARY PREVENTION OF VENOUS THROMBOEMBOLISM IN THE UK [J] . Clay E., Jamotte A., Cohen A. T., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：与沃法林相比，依多沙班在英国治疗和二次预防静脉血栓形成的成本效益
2. Dabigatran etexilate: A review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence [J] . GreigS.L., McKeageK. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2014,第15期

机译：达比加群酯：其在治疗急性静脉血栓栓塞和预防静脉血栓栓塞复发中的应用综述
3. Dabigatran etexilate: A review of its use in the treatment of acute venous thromboembolism and prevention of venous thromboembolism recurrence [J] . GreigS.L., McKeageK. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2014,第15期

机译：Dabigatran eTexilate：对急性静脉血栓栓塞治疗和预防静脉血栓栓塞复发的综述
4. Evaluation of the Symptoms of Acute Venous Thromboembolism [C] . R.A. Rached, L. Pereira, A. De Piano, International Congress on Thrombosis . 2004

机译：评价急性静脉血栓栓塞症状的症状
5. Cost-Effectiveness of Current Anticoagulation Care versus Genetic Testing of CYP2C9 and VKORC1 Prior to Long-Term Warfarin Anticoagulation Care: The Implementation of Discrete Event Simulation Model on the Natural History of Venous Thromboembolism. [D] . Teschemaker, Anna R. 2011

机译：当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系：基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
6. Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK [O] . Emilie Clay, Aurélien Jamotte, Peter Verhamme, 2018

机译：与华法林相比依多沙班在英国治疗和二级预防静脉血栓栓塞的成本效益
7. PCV78 The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban In The Treatment of Acute Venous Thromboembolism In The Uk [O] . Jugrin A.V., Ustyugova A.V., Lamotte M., 2015

机译：PCV78达比加群酯与依多沙班相比在英国急性静脉血栓栓塞治疗中的成本效益

PCV98 The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin In The Treatment And Secondary Prevention Of Acute Venous Thromboembolism In The Uk

著录项

引文网络

相似文献

相关主题

期刊订阅